Skip to content

ORBIMED ADVISORS LLC: NTRA position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on NTRA, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 262,000 NTRA shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 262,000 shares
    Change vs previous 13F 0 shares

    1.35% of the 13F portfolio, value $71,119,900.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 262,000 shares
    Change vs previous 13F -103,800 shares

    1.14% of the 13F portfolio, value $52,397,380.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 365,800 shares
    Change vs previous 13F -63,500 shares

    1.71% of the 13F portfolio, value $83,801,122.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 429,300 shares
    Change vs previous 13F -164,134 shares

    1.66% of the 13F portfolio, value $69,104,421.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 593,434 shares
    Change vs previous 13F +46,434 shares

    2.52% of the 13F portfolio, value $100,254,740.

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 547,000 shares
    Change vs previous 13F +134,000 shares

    1.86% of the 13F portfolio, value $77,351,270.

    13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 413,000 shares
    Change vs previous 13F -274,500 shares

    1.36% of the 13F portfolio, value $65,377,900.

    13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 687,500 shares
    Change vs previous 13F not available

    1.6% of the 13F portfolio, value $87,278,125.

    13F-HR 0001172661-24-005167 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).